Literature DB >> 24752258

In vitro amphotericin B susceptibility of Malassezia pachydermatis determined by the CLSI broth microdilution method and Etest using lipid-enriched media.

Sergio Álvarez-Pérez1, José L Blanco2, Teresa Peláez3, Maite Cutuli4, Marta E García4.   

Abstract

We determined the in vitro amphotericin B susceptibility of 60 Malassezia pachydermatis isolates by the CLSI broth microdilution method and the Etest using lipid-enriched media. All isolates were susceptible at MICs of ≤ 1 μg/ml, confirming the high activity of amphotericin B against this yeast species. Overall, the essential agreement between the tested methods was high (80% and 96.7% after 48 h and 72 h, respectively), and all discrepancies were regarded as nonsubstantial.
Copyright © 2014, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24752258      PMCID: PMC4068533          DOI: 10.1128/AAC.00091-14

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  25 in total

1.  Assessment of the antifungal susceptibility of Malassezia pachydermatis in various media using a CLSI protocol.

Authors:  Claudia Cafarchia; Luciana A Figueredo; Vincenza Favuzzi; Mariannna R Surico; Valeriana Colao; Roberta Iatta; Maria Teresa Montagna; Domenico Otranto
Journal:  Vet Microbiol       Date:  2012-05-02       Impact factor: 3.293

2.  Evaluation of the antifungal susceptibility of Malassezia pachydermatis to clotrimazole, miconazole and thiabendazole using a modified CLSI M27-A3 microdilution method.

Authors:  Andrea Peano; Massimo Beccati; Elisa Chiavassa; Mario Pasquetti
Journal:  Vet Dermatol       Date:  2012-02-07       Impact factor: 1.589

3.  Comparison of the Vitek 2 antifungal susceptibility system with the clinical and laboratory standards institute (CLSI) and European Committee on Antimicrobial Susceptibility Testing (EUCAST) Broth Microdilution Reference Methods and with the Sensititre YeastOne and Etest techniques for in vitro detection of antifungal resistance in yeast isolates.

Authors:  Manuel Cuenca-Estrella; Alicia Gomez-Lopez; Ana Alastruey-Izquierdo; Leticia Bernal-Martinez; Isabel Cuesta; Maria J Buitrago; Juan L Rodriguez-Tudela
Journal:  J Clin Microbiol       Date:  2010-03-10       Impact factor: 5.948

4.  [Mycoses in domestic animals].

Authors:  M E García; J L Blanco
Journal:  Rev Iberoam Micol       Date:  2000-03       Impact factor: 1.044

5.  In vitro susceptibility of fluconazole-susceptible and -resistant isolates of Malassezia pachydermatis against azoles.

Authors:  F P K Jesus; C Lautert; R A Zanette; D L Mahl; M I Azevedo; M L S Machado; V Dutra; S A Botton; S H Alves; J M Santurio
Journal:  Vet Microbiol       Date:  2011-04-22       Impact factor: 3.293

6.  In vitro antifungal susceptibility of Malassezia pachydermatis from dogs with and without skin lesions.

Authors:  Claudia Cafarchia; Luciana A Figueredo; Roberta Iatta; Maria Teresa Montagna; Domenico Otranto
Journal:  Vet Microbiol       Date:  2011-09-12       Impact factor: 3.293

7.  Phenotypic characterization and in vitro antifungal sensitivity of Candida spp. and Malassezia pachydermatis strains from dogs.

Authors:  Erika H S Brito; Raquel O S Fontenelle; Raimunda S N Brilhante; Rossana A Cordeiro; Franciso A Soares Júnior; André J Monteiro; José J C Sidrim; Marcos F G Rocha
Journal:  Vet J       Date:  2006-12-22       Impact factor: 2.688

8.  An epidemic of Malassezia pachydermatis in an intensive care nursery associated with colonization of health care workers' pet dogs.

Authors:  H J Chang; H L Miller; N Watkins; M J Arduino; D A Ashford; G Midgley; S M Aguero; R Pinto-Powell; C F von Reyn; W Edwards; M M McNeil; W R Jarvis
Journal:  N Engl J Med       Date:  1998-03-12       Impact factor: 91.245

9.  The anatomical distribution and antimicrobial susceptibility of yeast species isolated from healthy dogs.

Authors:  Erika H S Brito; Raquel O S Fontenelle; Raimunda S N Brilhante; Rossana A Cordeiro; André J Monteiro; José J C Sidrim; Marcos F G Rocha
Journal:  Vet J       Date:  2008-12-23       Impact factor: 2.688

10.  Subculture on potato dextrose agar as a complement to the broth microdilution assay for Malassezia pachydermatis.

Authors:  Marilena R Prado; Erika H S Brito; Raimunda S N Brilhante; Rossana A Cordeiro; João J G Leite; José J C Sidrim; Marcos F G Rocha
Journal:  J Microbiol Methods       Date:  2008-07-07       Impact factor: 2.363

View more
  5 in total

1.  In Vitro Azole and Amphotericin B Susceptibilities of Malassezia furfur from Bloodstream Infections Using E-Test and CLSI Broth Microdilution Methods.

Authors:  Wafa Rhimi; Chioma Inyang Aneke; Adriana Mosca; Domenico Otranto; Claudia Cafarchia
Journal:  Antibiotics (Basel)       Date:  2020-06-26

2.  Susceptibilities of Malassezia strains from pityriasis versicolor, Malassezia folliculitis and seborrheic dermatitis to antifungal drugs.

Authors:  Kaiqin Wang; Lu Cheng; Wenshuang Li; Hui Jiang; Xiaofang Zhang; Shanshan Liu; Yunli Huang; Mingyue Qiang; Tianxiang Dong; Yuye Li; Jin Wang; Shike Feng; Hongbin Li
Journal:  Heliyon       Date:  2020-06-20

3.  Susceptibility of Malassezia pachydermatis Clinical Isolates to Allopathic Antifungals and Brazilian Red, Green, and Brown Propolis Extracts.

Authors:  Kathleen Ramos Deegan; Maisa Santos Fonseca; Diogo Coelho Pádua Oliveira; Laerte Marlon Santos; Clara Couto Fernandez; Samira Abdallah Hanna; Bruna Aparecida Souza Machado; Marcelo Andrés Umsza-Guez; Roberto Meyer; Ricardo Wagner Portela
Journal:  Front Vet Sci       Date:  2019-12-13

Review 4.  Malassezia: Zoonotic Implications, Parallels and Differences in Colonization and Disease in Humans and Animals.

Authors:  Stefan Hobi; Claudia Cafarchia; Valentina Romano; Vanessa R Barrs
Journal:  J Fungi (Basel)       Date:  2022-07-04

5.  Exploration of anti-Malassezia potential of Nyctanthes arbor-tristis L. and their application to combat the infection caused by Mala s1 a novel allergen.

Authors:  Rohit K Mishra; Vani Mishra; Anand Pandey; Amit K Tiwari; Himanshu Pandey; Shivesh Sharma; Avinash C Pandey; Anupam Dikshit
Journal:  BMC Complement Altern Med       Date:  2016-03-31       Impact factor: 3.659

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.